City Holding Co. Sells 169 Shares of Colgate-Palmolive Company $CL

City Holding Co. reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 2.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,600 shares of the company’s stock after selling 169 shares during the period. City Holding Co.’s holdings in Colgate-Palmolive were worth $600,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in Colgate-Palmolive by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 81,758,257 shares of the company’s stock valued at $7,660,749,000 after acquiring an additional 455,198 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Colgate-Palmolive by 18.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after buying an additional 5,269,140 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Colgate-Palmolive by 34.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after buying an additional 2,045,191 shares during the last quarter. Deutsche Bank AG increased its holdings in shares of Colgate-Palmolive by 3.7% in the 1st quarter. Deutsche Bank AG now owns 7,176,598 shares of the company’s stock worth $672,447,000 after buying an additional 253,604 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in shares of Colgate-Palmolive by 2.6% in the 1st quarter. Ameriprise Financial Inc. now owns 6,976,654 shares of the company’s stock worth $653,761,000 after buying an additional 177,833 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Barclays boosted their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 15th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a report on Thursday. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, UBS Group decreased their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $97.73.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $79.57 on Monday. The firm has a market cap of $64.31 billion, a PE ratio of 22.35, a price-to-earnings-growth ratio of 4.14 and a beta of 0.35. The firm’s 50 day simple moving average is $84.19 and its 200-day simple moving average is $88.69. Colgate-Palmolive Company has a one year low of $78.76 and a one year high of $104.16. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.